Cargando…

Risk Factors for Prognosis in Patients With Severely Decreased GFR

INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Marie, Grams, Morgan E., Sang, Yingying, Astor, Brad C., Blankestijn, Peter J., Brunskill, Nigel J., Collins, John F., Kalra, Philip A., Kovesdy, Csaba P., Levin, Adeera, Mark, Patrick B., Moranne, Olivier, Rao, Panduranga, Rios, Pablo G., Schneider, Markus P., Shalev, Varda, Zhang, Haitao, Chang, Alex R., Gansevoort, Ron T., Matsushita, Kunihiro, Zhang, Luxia, Eckardt, Kai-Uwe, Hemmelgarn, Brenda, Wheeler, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976849/
https://www.ncbi.nlm.nih.gov/pubmed/29854970
http://dx.doi.org/10.1016/j.ekir.2018.01.002
_version_ 1783327247250227200
author Evans, Marie
Grams, Morgan E.
Sang, Yingying
Astor, Brad C.
Blankestijn, Peter J.
Brunskill, Nigel J.
Collins, John F.
Kalra, Philip A.
Kovesdy, Csaba P.
Levin, Adeera
Mark, Patrick B.
Moranne, Olivier
Rao, Panduranga
Rios, Pablo G.
Schneider, Markus P.
Shalev, Varda
Zhang, Haitao
Chang, Alex R.
Gansevoort, Ron T.
Matsushita, Kunihiro
Zhang, Luxia
Eckardt, Kai-Uwe
Hemmelgarn, Brenda
Wheeler, David C.
author_facet Evans, Marie
Grams, Morgan E.
Sang, Yingying
Astor, Brad C.
Blankestijn, Peter J.
Brunskill, Nigel J.
Collins, John F.
Kalra, Philip A.
Kovesdy, Csaba P.
Levin, Adeera
Mark, Patrick B.
Moranne, Olivier
Rao, Panduranga
Rios, Pablo G.
Schneider, Markus P.
Shalev, Varda
Zhang, Haitao
Chang, Alex R.
Gansevoort, Ron T.
Matsushita, Kunihiro
Zhang, Luxia
Eckardt, Kai-Uwe
Hemmelgarn, Brenda
Wheeler, David C.
author_sort Evans, Marie
collection PubMed
description INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with multiple comorbidities, which may distort associations between risk factors and clinical outcomes. METHODS: We undertook a meta-analysis of risk factors for kidney failure treated with kidney replacement therapy (KRT), cardiovascular disease (CVD) events, and death in participants with CKD G4+ from 28 cohorts (n = 185,024) across the world who were part of the CKD Prognosis Consortium. RESULTS: In the fully adjusted meta-analysis, risk factors associated with KRT were time-varying CVD, male sex, black race, diabetes, lower eGFR, and higher albuminuria and systolic blood pressure. Age was associated with a lower risk of KRT (adjusted hazard ratio: 0.74; 95% confidence interval: 0.69–0.80) overall, and also in the subgroup of individuals younger than 65 years. The risk factors for CVD events included male sex, history of CVD, diabetes, lower eGFR, higher albuminuria, and the onset of KRT. Systolic blood pressure showed a U-shaped association with CVD events. Risk factors for mortality were similar to those for CVD events but also included smoking. Most risk factors had qualitatively consistent associations across cohorts. CONCLUSION: Traditional CVD risk factors are of prognostic value in individuals with an eGFR <30 ml/min per 1.73 m(2), although the risk estimates vary for kidney and CVD outcomes. These results should encourage interventional studies on correcting risk factors in this high-risk population.
format Online
Article
Text
id pubmed-5976849
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59768492018-05-31 Risk Factors for Prognosis in Patients With Severely Decreased GFR Evans, Marie Grams, Morgan E. Sang, Yingying Astor, Brad C. Blankestijn, Peter J. Brunskill, Nigel J. Collins, John F. Kalra, Philip A. Kovesdy, Csaba P. Levin, Adeera Mark, Patrick B. Moranne, Olivier Rao, Panduranga Rios, Pablo G. Schneider, Markus P. Shalev, Varda Zhang, Haitao Chang, Alex R. Gansevoort, Ron T. Matsushita, Kunihiro Zhang, Luxia Eckardt, Kai-Uwe Hemmelgarn, Brenda Wheeler, David C. Kidney Int Rep Clinical Research INTRODUCTION: Patients with chronic kidney disease (CKD) and estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m(2) (corresponding to CKD stage G4+) comprise a minority of the overall CKD population but have the highest risk for adverse outcomes. Many CKD G4+ patients are older with multiple comorbidities, which may distort associations between risk factors and clinical outcomes. METHODS: We undertook a meta-analysis of risk factors for kidney failure treated with kidney replacement therapy (KRT), cardiovascular disease (CVD) events, and death in participants with CKD G4+ from 28 cohorts (n = 185,024) across the world who were part of the CKD Prognosis Consortium. RESULTS: In the fully adjusted meta-analysis, risk factors associated with KRT were time-varying CVD, male sex, black race, diabetes, lower eGFR, and higher albuminuria and systolic blood pressure. Age was associated with a lower risk of KRT (adjusted hazard ratio: 0.74; 95% confidence interval: 0.69–0.80) overall, and also in the subgroup of individuals younger than 65 years. The risk factors for CVD events included male sex, history of CVD, diabetes, lower eGFR, higher albuminuria, and the onset of KRT. Systolic blood pressure showed a U-shaped association with CVD events. Risk factors for mortality were similar to those for CVD events but also included smoking. Most risk factors had qualitatively consistent associations across cohorts. CONCLUSION: Traditional CVD risk factors are of prognostic value in individuals with an eGFR <30 ml/min per 1.73 m(2), although the risk estimates vary for kidney and CVD outcomes. These results should encourage interventional studies on correcting risk factors in this high-risk population. Elsevier 2018-01-11 /pmc/articles/PMC5976849/ /pubmed/29854970 http://dx.doi.org/10.1016/j.ekir.2018.01.002 Text en © 2018 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Research
Evans, Marie
Grams, Morgan E.
Sang, Yingying
Astor, Brad C.
Blankestijn, Peter J.
Brunskill, Nigel J.
Collins, John F.
Kalra, Philip A.
Kovesdy, Csaba P.
Levin, Adeera
Mark, Patrick B.
Moranne, Olivier
Rao, Panduranga
Rios, Pablo G.
Schneider, Markus P.
Shalev, Varda
Zhang, Haitao
Chang, Alex R.
Gansevoort, Ron T.
Matsushita, Kunihiro
Zhang, Luxia
Eckardt, Kai-Uwe
Hemmelgarn, Brenda
Wheeler, David C.
Risk Factors for Prognosis in Patients With Severely Decreased GFR
title Risk Factors for Prognosis in Patients With Severely Decreased GFR
title_full Risk Factors for Prognosis in Patients With Severely Decreased GFR
title_fullStr Risk Factors for Prognosis in Patients With Severely Decreased GFR
title_full_unstemmed Risk Factors for Prognosis in Patients With Severely Decreased GFR
title_short Risk Factors for Prognosis in Patients With Severely Decreased GFR
title_sort risk factors for prognosis in patients with severely decreased gfr
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976849/
https://www.ncbi.nlm.nih.gov/pubmed/29854970
http://dx.doi.org/10.1016/j.ekir.2018.01.002
work_keys_str_mv AT evansmarie riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT gramsmorgane riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT sangyingying riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT astorbradc riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT blankestijnpeterj riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT brunskillnigelj riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT collinsjohnf riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT kalraphilipa riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT kovesdycsabap riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT levinadeera riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT markpatrickb riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT moranneolivier riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT raopanduranga riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT riospablog riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT schneidermarkusp riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT shalevvarda riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT zhanghaitao riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT changalexr riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT gansevoortront riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT matsushitakunihiro riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT zhangluxia riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT eckardtkaiuwe riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT hemmelgarnbrenda riskfactorsforprognosisinpatientswithseverelydecreasedgfr
AT wheelerdavidc riskfactorsforprognosisinpatientswithseverelydecreasedgfr